Cargando…

Super(antigen) target for SARS-CoV-2

This preprint further characterizes a superantigen motif identified in SARS-CoV-2 spike protein and evaluates a monoclonal antibody targeting this region that can neutralize live virus.

Detalles Bibliográficos
Autores principales:	Brown, Matthew, Bhardwaj, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798007/ https://www.ncbi.nlm.nih.gov/pubmed/33432128 http://dx.doi.org/10.1038/s41577-021-00502-5

Ejemplares similares

Profiling and characterization of SARS-CoV-2 mutants’ infectivity and antigenicity
por: Wang, Lin, et al.
Publicado: (2020)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

SARS-CoV-2: the many pros of targeting PLpro
por: McClain, Christopher B., et al.
Publicado: (2020)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

SARS-CoV-2 sensory loss
por: York, Ashley
Publicado: (2022)

Sewer biofilms and SARS-CoV-2
por: Du Toit, Andrea
Publicado: (2023)

SURFing SARS-CoV-2 inhibition
por: Taglialegna, Agustina
Publicado: (2023)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

SARS-CoV-2 nanobodies 2.0
por: Labroussaa, Fabien, et al.
Publicado: (2021)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

A CNS gateway for SARS-CoV-2
por: Yates, Darran
Publicado: (2021)

SARS-CoV-2 detected in olfactory neurons
por: Lemprière, Sarah
Publicado: (2021)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Cellular basis for SARS-CoV-2 infection
por: Baumann, Kim
Publicado: (2020)

Effects of mutations on SARS-CoV-2 fitness
por: Chirigati, Fernando
Publicado: (2022)

SARS-CoV-2 rewires host chromatin
por: Du Toit, Andrea
Publicado: (2023)

Landscapes of SARS-CoV-2-reactive CD8(+) T cells: heterogeneity of host immune responses against SARS-CoV-2
por: Koh, June-Young, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: flexibility as a new target for fighting infection
por: Pierri, Ciro Leonardo
Publicado: (2020)

SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target
por: Giovannoni, Federico, et al.
Publicado: (2020)

TMPRSS2, a novel host-directed drug target against SARS-CoV-2
por: Keller, Christian, et al.
Publicado: (2022)

Effects of pancreatic SARS-CoV-2 infection identified
por: Morris, Alan
Publicado: (2021)

SARS-CoV-2 and the brain to be studied long-term
por: Lemprière, Sarah
Publicado: (2020)

Keeping track of the SARS-CoV-2 vaccine pipeline
por: Parker, Edward P. K., et al.
Publicado: (2020)

Lack of maternal–fetal SARS-CoV-2 transmission
por: Stower, Hannah
Publicado: (2020)

Organoids demonstrate gut infection by SARS-CoV-2
por: Dickson, Iain
Publicado: (2020)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

A two‐step infection model: From SARS‐CoV‐2 entry and trafficking to egress and spread
por: You, Liting, et al.
Publicado: (2023)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

D614G and SARS-CoV-2 replication fitness
por: Engelman, Kathleen D., et al.
Publicado: (2021)

Artificially intelligent nanopore for rapid SARS-CoV-2 testing
por: Horejs, Christine
Publicado: (2021)

The SARS-CoV-2 spike protein: balancing stability and infectivity
por: Berger, Imre, et al.
Publicado: (2020)

STING, a critical contributor to SARS-CoV-2 immunopathology
por: Li, Heyu, et al.
Publicado: (2022)

AngII autoantibodies after SARS-CoV-2 infection
por: Wang, Monica
Publicado: (2022)

ZBP1 inflames the SARS-CoV-2-infected lung
por: Yin, Chaoran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hv8k9o13shcaclbmv8u9aqa7mn